Researchers at the University of Pennsylvania recently published a very rare adverse effect in CAR-T therapies. A lentiviral vector bonded to the wrong cell and subsequently, the patient suffered a fatal relapse, with all of the leukemic cells carrying the chimeric antigen receptor. While the risk of similar incidents happening today has decreased, they are still possible.